viscocanalostomy: Definition, Uses, and Clinical Overview

Posted on February 27, 2026 | by dreye

viscocanalostomy Introduction (What it is)

viscocanalostomy is a type of glaucoma surgery designed to lower eye pressure.
It is usually used for open-angle forms of glaucoma when drops or laser are not enough.
It works by improving the eye’s natural drainage pathways without fully entering the front chamber of the eye.
It is considered a “non-penetrating” filtering surgery in many surgical classifications.

Why viscocanalostomy used (Purpose / benefits)

Glaucoma is a group of diseases in which damage to the optic nerve is often associated with elevated intraocular pressure (IOP), the fluid pressure inside the eye. Lowering IOP is the main modifiable factor clinicians target to slow glaucoma progression. Medicated eye drops and laser treatments can reduce IOP for many people, but some patients need an incisional procedure to reach an IOP goal or to reduce treatment burden.

viscocanalostomy is used to improve aqueous humor outflow. Aqueous humor is the clear fluid produced inside the eye that normally drains through a structure called the trabecular meshwork into Schlemm’s canal and then into collector channels. In open-angle glaucoma, outflow resistance is often increased around this drainage region.

Potential benefits often discussed for viscocanalostomy (compared with some traditional filtering surgeries) include:

Lowering IOP by enhancing the eye’s natural drainage route (rather than creating a full-thickness opening into the anterior chamber).
Reducing the likelihood of very low eye pressure (hypotony) in the early postoperative period, relative to procedures that intentionally create a direct opening into the eye.
Offering an option for patients where clinicians are aiming for meaningful pressure reduction with a different risk profile than trabeculectomy.

The exact IOP response and whether a patient can reduce or stop glaucoma drops after surgery varies by clinician and case, and depends on glaucoma type, disease stage, and postoperative healing.

Indications (When ophthalmologists or optometrists use it)

Typical situations where viscocanalostomy may be considered include:

Primary open-angle glaucoma with inadequate IOP control on medications and/or laser
Pseudoexfoliation glaucoma (an open-angle glaucoma subtype), in selected cases
Pigmentary glaucoma (another open-angle subtype), in selected cases
Ocular hypertension with evidence of progression or high risk, in selected cases
Patients in whom a surgeon prefers a non-penetrating glaucoma approach based on anatomy and risk considerations
Cases where the clinician wants to target Schlemm’s canal and the trabecular outflow pathway
Situations where cataract surgery and glaucoma surgery may be planned together (combined approaches vary by clinician and case)

Optometrists typically do not perform viscocanalostomy, but they may participate in identifying progression, educating patients, and coordinating perioperative care with ophthalmology.

Contraindications / when it’s NOT ideal

viscocanalostomy is not suitable for every glaucoma type or eye. Situations where it may be less ideal, not feasible, or less effective include:

Angle-closure glaucoma without adequate angle opening (because access to the trabecular outflow system is limited)
Neovascular glaucoma (new abnormal vessels and scarring can block drainage pathways)
Uveitic or inflammatory glaucoma with active or recurrent inflammation (risk of scarring and variable pressure behavior)
Eyes with significant conjunctival or scleral scarring from prior surgery or trauma in the intended surgical area (may limit surgical success)
Advanced glaucoma where extremely low target pressures are needed (procedure choice varies by clinician and case)
Anatomies that make identification or unroofing of Schlemm’s canal difficult (varies by eye and surgeon)
Certain secondary glaucomas where the primary problem is not mainly trabecular outflow resistance (case-dependent)

Choice of procedure is individualized. In some cases, a different non-penetrating procedure, trabeculectomy, tube shunt surgery, or a minimally invasive glaucoma surgery (MIGS) approach may be preferred.

How it works (Mechanism / physiology)

At a high level, viscocanalostomy aims to reduce IOP by improving aqueous humor drainage through the conventional outflow pathway.

Mechanism of action (high level)

The procedure involves creating a controlled surgical “window” in the sclera (the white outer coat of the eye) and exposing Schlemm’s canal, which is a circular channel that normally collects aqueous humor from the trabecular meshwork. A viscoelastic substance is injected into Schlemm’s canal to dilate (expand) the canal and potentially improve flow through the canal and connected collector channels. The surgery also creates a space under the sclera (often described as a subscleral lake) that can serve as a reservoir to facilitate fluid movement.

Because it is generally categorized as non-penetrating, the anterior chamber (the fluid-filled space between the cornea and iris) is typically not opened in a full-thickness manner during the intended technique. Instead, aqueous humor is encouraged to percolate through a thin remaining tissue layer near the drainage region.

Relevant anatomy (what structures are involved)

Key structures often discussed in relation to viscocanalostomy include:

Trabecular meshwork (TM): the tissue that provides resistance and filtration for aqueous outflow.
Schlemm’s canal: the circular drainage channel receiving aqueous from the TM.
Collector channels / episcleral venous system: pathways that carry fluid away from Schlemm’s canal into veins.
Sclera: where superficial and deeper scleral flaps are created during surgery.
Descemet’s membrane region / “Descemet’s window”: a thin area near the cornea-sclera junction where controlled filtration/percolation may occur in non-penetrating techniques.

Onset, duration, and reversibility (what applies here)

Onset: IOP reduction can occur soon after surgery, but the final pressure profile often evolves as tissues heal and remodel.
Duration: Long-term effectiveness varies by clinician and case, and can be influenced by scarring, the severity and type of glaucoma, and postoperative management.
Reversibility: It is a surgical structural change and is not “reversible” in the way a medication is. However, additional interventions may be performed if pressure remains high or rises over time (for example, laser adjustment procedures in some non-penetrating approaches, or conversion to another glaucoma surgery).

viscocanalostomy Procedure overview (How it’s applied)

viscocanalostomy is an operating-room glaucoma procedure performed by an ophthalmologist (typically a glaucoma specialist). Exact steps and instruments vary by surgeon and eye anatomy, but a general workflow is:

Evaluation / exam – Assessment of glaucoma type and severity, current IOP control, optic nerve status, and visual field findings – Examination of the anterior segment and angle anatomy (often with gonioscopy) – Review of prior eye surgeries and ocular surface health
Preparation – Surgical planning, including anesthesia approach (commonly local anesthesia with sedation, depending on setting and patient factors) – Sterile preparation of the eye and surrounding area
Intervention – Creation of a superficial scleral flap – Dissection of a deeper scleral flap to unroof Schlemm’s canal and create a thin membrane over the anterior chamber region (in many descriptions, a trabeculo-Descemet’s membrane is left intact) – Viscodilation: injection of a viscoelastic material into Schlemm’s canal ostia to expand the canal – Closure of the superficial flap and conjunctiva in a way intended to support controlled outflow
Immediate checks – Confirmation of wound integrity and anterior chamber stability – Early postoperative IOP and inflammation assessment (timing varies by clinic)
Follow-up – Scheduled visits to monitor IOP, healing, and signs of scarring or inadequate pressure lowering – Adjustment of medications and consideration of additional procedures if IOP targets are not met (approach varies by clinician and case)

This overview is intentionally high-level; surgeons tailor technique details to the individual eye and intraoperative findings.

Types / variations

viscocanalostomy is part of a broader family of glaucoma surgeries that target the conventional outflow system. Common variations and related concepts include:

Standalone viscocanalostomy
Performed as the primary glaucoma procedure when cataract surgery is not being done at the same time.
Combined cataract surgery plus viscocanalostomy
Sometimes performed when a visually significant cataract is present and a combined plan is appropriate. The combined approach is often referred to in clinical conversation as a combined phacoemulsification (cataract removal) with a non-penetrating glaucoma surgery. Naming conventions vary.
Use of adjunct implants or spacers (surgeon-dependent)
Some non-penetrating surgeries use implants in the scleral lake to reduce collapse or scarring. Whether these are used with viscocanalostomy depends on surgeon preference and local practice patterns. Performance varies by material and manufacturer.
Postoperative enhancement procedures (case-dependent)
In non-penetrating glaucoma surgery broadly, if IOP remains higher than desired, clinicians may consider laser procedures that increase flow through the remaining membrane (often described as goniopuncture in related techniques). Whether and how often this is used varies by clinician and case.
Related procedures often compared with viscocanalostomy
Deep sclerectomy: another non-penetrating filtering surgery with overlapping concepts.
Canaloplasty: a Schlemm’s canal–based procedure that uses circumferential catheterization and tensioning (technique differs, but both aim to enhance conventional outflow).

Pros and cons

Pros:

Targets the eye’s natural drainage pathway (trabecular meshwork/Schlemm’s canal system)
Often described as non-penetrating, which can change the early risk profile compared with full-thickness filtering surgeries
May reduce IOP and, in some cases, reduce reliance on glaucoma drops (varies by clinician and case)
Can be planned as a standalone glaucoma surgery or combined with cataract surgery in selected patients
Typically uses a small internal reservoir (subscleral lake) to facilitate controlled filtration/percolation
May be an option when a clinician wants to avoid a direct opening into the anterior chamber as the primary mechanism

Cons:

Results depend heavily on healing and scarring responses, which are patient-specific
Not ideal for many non–open-angle glaucoma types (for example, neovascular or active inflammatory glaucomas)
May not achieve very low target IOPs needed in some advanced cases (varies by clinician and case)
Technically demanding surgery with a learning curve; outcomes can be surgeon-dependent
Some patients still need glaucoma medications after surgery
Additional postoperative procedures may be needed if IOP remains above target (type and frequency vary)

Aftercare & longevity

Aftercare following viscocanalostomy focuses on monitoring healing, inflammation, and IOP over time. Postoperative routines differ across practices, but commonly emphasize:

Follow-up timing and frequency: often more frequent early on, then spaced out as the eye stabilizes.
IOP monitoring: IOP can fluctuate during healing, and scarring can reduce the long-term drainage effect.
Inflammation control and wound management: clinicians commonly use anti-inflammatory and antibiotic drops after eye surgery, but the exact regimen and duration varies by clinician and case.
Watching for changes in vision: temporary blur can occur after surgery due to surface irritation, inflammation, or refractive shifts; persistent changes are evaluated case-by-case.
Long-term glaucoma surveillance: even with successful IOP lowering, glaucoma monitoring usually continues with optic nerve exams and visual field testing.

Longevity of IOP control after viscocanalostomy varies. Factors that can influence longer-term outcomes include:

Baseline glaucoma severity and target IOP requirements
Individual scarring response (healing biology differs between patients)
Coexisting eye conditions (for example, ocular surface disease, prior surgery, or inflammation)
Adherence to scheduled follow-ups and clinician-directed postoperative plans
Whether the surgery was combined with cataract surgery and the specifics of technique and materials used (varies by clinician, material, and manufacturer)

Alternatives / comparisons

Choice among glaucoma treatments typically weighs expected IOP reduction, side-effect profile, disease stage, and patient-specific factors. Common alternatives that clinicians may discuss include:

Observation / monitoring
Considered when glaucoma is mild, stable, or when the risks of intervention outweigh expected benefits. Monitoring does not lower IOP by itself but can be appropriate in selected situations.
Medications (eye drops and sometimes oral agents)
Often first-line for open-angle glaucoma. Drops can be effective but may have side effects, cost/access issues, and adherence challenges.
Laser trabeculoplasty (e.g., SLT)
A non-incisional option that can reduce IOP by improving trabecular outflow. Effect size and duration vary, and repeatability depends on the clinical context.
MIGS (minimally invasive glaucoma surgery)
A broad category including trabecular bypass or tissue removal procedures, often combined with cataract surgery. MIGS may offer a different balance of IOP lowering versus risk; the appropriate choice depends on target IOP and glaucoma severity.
Trabeculectomy
A traditional filtering surgery that creates a guarded fistula to drain fluid to a bleb under the conjunctiva. It can achieve low IOPs in many cases but may involve more intensive postoperative management and different complication risks.
Glaucoma drainage devices (tube shunts)
Often used in complex or refractory glaucomas, or when prior surgeries have failed. They route aqueous to an external plate reservoir.

Compared with these options, viscocanalostomy is commonly framed as an intermediate approach for selected open-angle glaucoma patients: more invasive than drops or laser, but generally designed to avoid a full-thickness anterior chamber entry as the primary outflow route. The best comparison for an individual patient depends on anatomy, disease stage, and clinician goals.

viscocanalostomy Common questions (FAQ)

Q: Is viscocanalostomy a cataract surgery?
No. viscocanalostomy is a glaucoma surgery intended to lower intraocular pressure. It may be combined with cataract surgery in some patients, but it is a different procedure with a different goal.

Q: Does viscocanalostomy hurt?
During surgery, anesthesia is used to reduce pain. After surgery, discomfort or a scratchy sensation can occur and is monitored by the clinical team. Individual experience varies.

Q: How long does it take to recover?
Healing timelines vary, and vision can fluctuate as inflammation settles and the ocular surface recovers. Clinics typically schedule multiple follow-ups early on to track IOP and healing. Full stabilization can take weeks to months depending on the eye and postoperative course.

Q: How long do the pressure-lowering results last?
Duration varies by clinician and case. Some eyes maintain improved IOP control for years, while others experience reduced effect over time due to scarring or disease progression. Ongoing monitoring is still needed.

Q: Is viscocanalostomy considered “safe”?
All surgeries have risks, and “safe” depends on the individual patient and the alternative options. viscocanalostomy is often discussed as having a different complication profile than full-thickness filtering surgery because it is generally non-penetrating. A surgeon will weigh expected benefits against risks for a specific eye.

Q: Will I still need glaucoma drops after viscocanalostomy?
Some patients can reduce medications, while others still need drops to reach their target IOP. The outcome depends on baseline pressure, glaucoma severity, and healing response. Medication plans are individualized.

Q: What is the cost of viscocanalostomy?
Cost depends on healthcare system, insurance coverage, facility and surgeon fees, and whether it is combined with other procedures. Because these variables are large, cost is usually discussed with the clinic and billing team rather than estimated reliably in general articles.

Q: Can I drive or use screens after surgery?
Activity restrictions and timing vary by clinician and by how the eye is healing. Vision can be temporarily blurred, which can affect driving safety regardless of formal restrictions. Screen use is often possible, but comfort may be limited if the eye is irritated or dry.

Q: What happens if viscocanalostomy does not lower the pressure enough?
If IOP remains above target, clinicians may adjust medications, consider office-based enhancements used in some non-penetrating surgeries, or recommend another glaucoma procedure. The next step depends on the reason for inadequate control (for example, scarring, disease severity, or anatomy). Management is individualized.

Q: Can viscocanalostomy be done in both eyes?
Glaucoma often affects both eyes, but surgeries are typically planned eye-by-eye rather than simultaneously. Timing depends on disease severity, response in the first eye, and practical considerations. The treating surgeon determines the safest sequence for the individual patient.